Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

GSK excited about new vaccines

July 4, 2005 Sales and Marketing

GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …
News

Bright future for new antidepressants

June 30, 2005 Research and Development, Sales and Marketing

News

Humira receives two European recommendations

June 29, 2005 Sales and Marketing

Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …
News

New products key to Schering growth

June 29, 2005 Sales and Marketing

Schering has reiterated its goal of achieving an 18% operating margin in 2006 and is predicting further growth in the …
News

FDA approves new HIV drug Aptivus

June 29, 2005 Sales and Marketing

Boehringer Ingelheim's new HIV drug Aptivus has been granted accelerated approval by the FDA. Aptivus (tipranavir) has been approved for …
News

GSK forms hypertension alliance

June 29, 2005 Sales and Marketing

GlaxoSmithKline has formed a strategic alliance with an emerging pharma company to develop and commercialise novel compounds to treat hypertension …
News

FDA approves first ‘ethnic’ heart drug

June 29, 2005 Research and Development, Sales and Marketing

The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …
News

People Strategies launch

June 28, 2005 Sales and Marketing

A new company has been launched to bring people and change management expertise to companies that are not able to …
News

Roche’s Tarceva approaches EU approval

June 28, 2005 Sales and Marketing

Roche's new oral cancer treatment Tarceva has received a recommendation from the EMEA's advisory committee, paving the way for its …
News

Pfizer hits out at NICE’s statin guidance

June 28, 2005 Sales and Marketing

News

The myth of the ‘S-shaped’ curve

June 28, 2005 Sales and Marketing

Feature

AstraZeneca’s defeat opens door to more challenges

June 24, 2005 Sales and Marketing

Pharmaceutical companies found guilty of violating European antitrust laws can expect steeper fines than AstraZeneca, according to a leading law …
News

Side-effect doubts cloud future of Pargluva and Galida

June 24, 2005 Sales and Marketing

A study comparing novel treatment Pargluva with a best-selling diabetes drug has yielded some positive results for the new drug, …
News

Acomplia filed in Europe and US

June 24, 2005 Sales and Marketing

Sanofi-Aventis has submitted its new obesity treatment Acomplia to the European Union and US regulators.Even before its filing Acomplia (rimonabant) …
News

Novartis hails new MS pill as a breakthrough

June 23, 2005 Sales and Marketing

Novartis says its new multiple sclerosis  treatment is more effective than existing drugs in delaying the progress of the disease, …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026